Skip to main content
Ion Beam Applications, SA logo

Ion Beam Applications, SA — Investor Relations & Filings

Ticker · IBAB ISIN · BE0003766806 LEI · 5493002RVRZ1S3CPUI26 BR Manufacturing
Open in API
Filings indexed 1,069 across all filing types
Latest filing 2025-05-22 Earnings Release
Country BE Belgium
Listing BR IBAB

About Ion Beam Applications, SA

https://www.iba-worldwide.com/

Ion Beam Applications (IBA) is a global company specializing in particle accelerator technology. It designs, manufactures, and markets advanced solutions for medical and industrial applications. The company is a leading supplier of proton therapy systems for the treatment of cancer. Its portfolio also includes dosimetry and quality assurance solutions for radiation therapy and medical imaging, as well as integrated systems for the production of radiopharmaceuticals (RadioPharma Solutions). Additionally, IBA provides industrial solutions, utilizing electron beam and X-ray accelerators for applications such as medical device sterilization and polymer modification.

Recent filings

Filing Released Lang Actions
250522-IBA-Trading-Update-Q1-2025-EN.pdf
Earnings Release Classification · 1% confidence The document is explicitly titled "IBA Business Update Q1 2025" and dated May 22, 2025. It provides a summary of the company's performance, backlog, cash position, commercial activities (Proton Therapy, Dosimetry, Technologies), management changes (CFO appointment), and outlook for 2025 and mid-term. This content structure—a periodic update on business performance and outlook, distinct from a full statutory report (like 10-K or IR)—aligns best with an Earnings Release (ER) or potentially an Interim Report (IR). Since it is a 'Business Update' focusing on key highlights and outlook rather than a comprehensive set of IFRS/GAAP financial statements typical of a full Interim Report (IR), and it serves as the initial announcement of period results, 'ER' (Earnings Release) is the most appropriate classification. It is not a transcript (CT), a presentation (IP), or a formal regulatory filing announcement (RPA/RNS). Q1 2025
2025-05-22 English
250522_Group-Business-Update-Q1-2025-FR.pdf
Earnings Release Classification · 1% confidence The document is titled "IBA déclaration intermédiaire - premier trimestre 2025" (IBA interim statement - first quarter 2025) and explicitly states it is publishing the review of activities for the first quarter ending March 31, 2025. It provides key financial highlights (cash position, order book), operational updates, management commentary, and forward-looking guidance (Guidance à un an (2025) and Prévisions à moyen terme (2024-2028)). This structure is characteristic of a comprehensive financial report covering a period shorter than a full year, which aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not merely an announcement of a report (RPA) as it contains the substantive content, nor is it the full Annual Report (10-K). Q1 2025
2025-05-22 French
PR week 08 - Buyback - IBA - March 2025 (EN).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'IBA – ACQUISITION OF OWN SHARES' and explicitly details the repurchase of IBA ordinary shares on Euronext Brussels between May 13th and May 19th, 2025. It provides tables showing the number of shares purchased, average price, and the resulting total treasury shares. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2025-05-19 English
PR week 08 - Buyback - IBA - March 2025 (FR).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'IBA – ACQUISITION D'ACTIONS PROPRES' (IBA - Acquisition of Own Shares) and details the number of shares repurchased by the company (IBA) on Euronext Brussels between May 13, 2025, and May 19, 2025. It provides specific transaction details (date, quantity, price range) and updates the total number of treasury shares held. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). The document is a direct report of this activity, not an announcement of a report.
2025-05-19 French
PR week 07 - Buyback - IBA - March 2025 (EN).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'IBA – ACQUISITION OF OWN SHARES' and explicitly details the repurchase of IBA ordinary shares on Euronext Brussels between May 6th and May 12th, 2025. It provides transaction dates, prices, amounts, and the resulting treasury share count. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2025-05-12 English
PR week 07 - Buyback - IBA - March 2025 (FR).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'IBA – ACQUISITION D'ACTIONS PROPRES' (IBA - Acquisition of Own Shares) and is dated May 12, 2025. It explicitly details the number of shares repurchased by the company (IBA) on Euronext Brussels between May 6 and May 12, 2025, including transaction dates, volumes, and prices. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is short (3898 chars), but it is a detailed report of transactions, not just an announcement that a report is available, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule.
2025-05-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.